“United States Wound Care Management Procedures Outlook to 2020″, provides key procedures data on the United States Wound Care Management Procedures. The report provides procedure volumes within market categories Tissue Engineered Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures), Wound Debridement Procedures and Ostomy Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

• Procedure volumes data for Wound Care Management Procedures segments Tissue Engineered Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures), Wound Debridement Procedures and Ostomy Procedures.
• Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

• Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Develop market-entry and market expansion strategies.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Introduction 4
2.1 What Is This Report About? 4
2.2 Wound Care Management Procedures Segmentation 4
2.3 Definitions of Procedures Covered in the Report 4

3 Wound Care Management, United States 6
3.1 Wound Care Management, United States, 2005-2020 6
3.2 Wound Care Management, United States Category Comparison by Procedures, 2005-2020 8
3.3 Wound Care Management, United States, 2005-2013 9
3.4 Wound Care Management, United States, 2013-2020 11

4 Ostomy Procedures, United States 13
4.1 Ostomy Procedures, United States, 2005-2013 13
4.2 Ostomy Procedures, United States, 2013-2020 15

5 Tissue Engineered - Skin Substitute Procedures, United States 17
5.1 Tissue Engineered - Skin Substitute Procedures, United States, 2005-2013 17
5.2 Tissue Engineered - Skin Substitute Procedures, United States, 2013-2020 19
5.2.1 Biologic Skin Substitute Procedures, United States, 2005-2013 21
5.2.1.1 Allograft Procedures, United States, 2005-2013 23
5.2.2 Biologic Skin Substitute Procedures, United States, 2013-2020 25
5.2.2.1 Allograft Procedures, United States, 2013-2020 27

6 Wound Debridement Procedures, United States 29
6.1 Wound Debridement Procedures, United States, 2005-2013 29
6.2 Wound Debridement Procedures, United States, 2013-2020 31

7 Appendix 32
7.1 Research Methodology 33
7.1.1 Coverage 33
7.1.2 Secondary Research 33
7.1.3 Primary Research 34
7.1.4 Market Modeling and Forecasting 35
7.1.5 Company Share Analysis 38
7.1.6 Distribution Share Analysis 39
7.2 Expert Panel 39
7.3 GlobalData Consulting 40
7.4 Contact Us 40
7.5 Disclaimer 40

List of Tables

Table 1: Wound Care Management, United States, 2005-2020 7
Table 2: Wound Care Management, United States Category Comparison by Procedures, 2005-2020 8
Table 3: Wound Care Management, United States, Historic, 2005-2013 10
Table 4: Wound Care Management, United States, Forecast, 2013-2020 12
Table 5: Ostomy Procedures, United States, Historic, 2005-2013 14
Table 6: Ostomy Procedures, United States, Forecast, 2013-2020 16
Table 7: Tissue Engineered - Skin Substitute Procedures, United States, Historic, 2005-2013 18
Table 8: Tissue Engineered - Skin Substitute Procedures, United States, Forecast, 2013-2020 20
Table 9: Biologic Skin Substitute Procedures, United States, Historic, 2005-2013 22
Table 10: Allograft Procedures, United States, Historic, 2005-2013 24
Table 11: Biologic Skin Substitute Procedures, United States, Forecast, 2013-2020 26
Table 12: Allograft Procedures, United States, Forecast, 2013-2020 28
Table 13: Wound Debridement Procedures, United States, Historic, 2005-2013 30
Table 14: Wound Debridement Procedures, United States, Forecast, 2013-2020 31
Table 15: Total Number of Primary Research Participants, Wound Care Management, by Country 35

Complete report available @ http://www.rnrmarketresearch.com/united-states-wound-care-management-procedures-outlook-to-2020-market-report.html .